[1]Wu H,Zhang J.miR-124 rs531564 polymorphism influences genetic susceptibility to cervical cancer[J].Int J Clin Exp Med,2014,7(12):5847-5851.
[2]Stanley MA.Immune responses to human papilloma viruses[J].Indian J Med Res,2009,130(3):266-276.
[3]Dunn GP,Old LJ,Schreiber RD.The three Es of cancer immunoediting[J].Annu Rev Immunol,2004,22:329-360.
[4]Zhang Y,Ding AP.Correlation state of HPV-16 existential status with Th17/Treg cytokine[J].National Medical Journal of China,2013,93(37):2957-2960.
[5]Uhlig HH,Coombes J,Mottet C,et al.Characterization of FoxP3(+)CD4(+)CD25(+) and IL-10-secreting CD4(+)CD25(+) T cells during cure of colitis[J].Journal of Immunology,2006,177(9):5852-5860.
[6]Collison LW,Workman CJ,Kuo TT,et al.The inhibitory cytokine IL-35 contributes to regulatory T-cell function[J].Nature,2007,450(7169):566-569.
[7]Hori S,Nomura T,Sakaguchi S.Control of regulatory T cell development by the transcription factor FoxP3[J].Science,2003,299(5609):1057-1061.
[8]Fontenot JD,Gavin MA,Rudensky AY.FoxP3 programs the development and function of CD4+CD25+ regulatory T cells[J].Nat Immunol,2003,4(4):330-336.
[9]Li YQ,Liu FF,Zhang XM,et al.Tumor secretion of CCL22 activates intratumoral Treg infiltration and is independent prognostic predictor of breast cancer[J].PLoS One,2013,8(10):e76379.
[10]Kurman RJ,Carcangiu ML,Herrington CS,et al.WHO classification of tumors of female reproductive organs[M].Lyon:IARC Press,2014:179.
[11]Kim M,Grimmig T,Grimm M,et al.Expression of FoxP3 in colorectal cancer but not in Treg cells correlates with disease progression in patients with colorectal cancer[J].PLoS One,2013,8(1):e53630.
[12]De Reuver PR,Mehta S,Gill P,et al.Immunoregulatory forkhead box protein p3-positive lymphocytes are associated with overall survival in patients with pancreatic neuroendocrine tumors[J].J Am Coll Surg,2016,223(3):281-287.
[13]Lin SZ,Chen KJ,Xu ZY,et al.Prediction of recurrence and survial in hepatocellular carcinoma based on two Cox models mainly determined by FoxP3+ regulatory T cells[J].Cancer Prev Res(Phila),2013,6(6):594-602.
[14]Winkler I,Wilczynska B,Bojarska-Junak A,et al.Regulatory T lymphocytes and transforming growth factor beta in epithelial ovarian tumors-prognostic significance[J].J Ovarian Res,2015,8:39.
[15]Luo Q,Jin Z,Chen S,et al.Changes of TRGV genes and prognosis-related chemokine/receptor gene expressions in T cell lymphoma[J].Chin J Cell Mol Imm,2017,33(3):362-366.
[16]Nakamura ES,Koizumi K,Kobayashi M,et al.RANKL-induced CCL22/macrophage-derived chemokine produced from osteoclasts potentially promotes the bone metastasis of lung cancer expressing its receptor CCR4[J].Clin Exp Metastasis,2006,23 (1):9-18.
[17]Gobert M,Treilleux I,Bendriss-Vermare N,et al.Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome[J].Cancer Res,2009,69(5):2000-2009.
[18]Gong SC,Zhang HD,Xing GQ,et al.The role of CD 4+CD25+T regs and CCL17,CCL22 in the pathogenesis of head and neck squamous cell carcinoma[J].Journal of Clinical Otorhinolarynogology Head and Neck Surgery,2017,31(20):1557-1560.
[19]Woo YL,van den Hende M,Sterling JC,et al.A prospective study on the natural course of low-grade aquamous intraepithelial lesions and the presence of HPV16 E2,E6 and E7-specific T-cell responses[J].Int J Cancer,2010,126(1):133-141.
[20]Ghosh A,Dasgupta A,Ghosh T,et al.A study of the expression and localization of toll-like receptors 2 and 9 in different grades of cervical intraepithelial neoplasia and squamous cell carcinoma[J].Exp Mol Patho,2015,99(3):720-724.
[21]Chiantore MV,Mangino G,Luliano M,et al.IFN-β antiproliferative effect and miRNA regulation in human papilloma virus E6- and E7-transfected keratinocyte[J].Cytokine,2015,89:235-238.
[22]Barros MR,De Oliveira THA,De Melo CML,et al.Viral modulation of TLRs and cytokines and the related immunotherapies for HPV-associated cancers[J].J Immunol Res,2018,2018:2912671.